Close Menu

NEW YORK (360Dx) – Abbott today announced the commencement of a cash tender offer for all outstanding shares of Alere's Series B convertible perpetual preferred stock.

The purchase of the preferred stock at $402 per share is in connection to Abbott's $5.3 billion acquisition of Alere. Alere shareholders approved the acquisition earlier this month.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.